The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer

Molecular classifications of breast cancer (BRC), such as human epidermal growth factor receptor 2 (HER2), luminal A and luminal B, have been developed to reduce unnecessary treatment by dividing patients with BRC into low- and high-risk progression groups. However, these methods do not cover all of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Oncol
Glavni autori: Kim, Seon-Kyu, Kim, Kwangho, Ryu, Jea-Woon, Ryu, Tae-Young, Lim, Jung Hwa, Oh, Jung-Hwa, Min, Jeong-Ki, Jung, Cho-Rok, Hamamoto, Ryuji, Son, Mi-Young, Kim, Dae-Soo, Cho, Hyun-Soo
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2018
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254934/
https://ncbi.nlm.nih.gov/pubmed/30365075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4608
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items